(Q37171151)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Developing new treatments for Alzheimer's disease: the who, what, when, and how of biomarker-guided therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Constantine G. Lyketsos

1

object named as

Constantine G Lyketsos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Christine A Szekely

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Paul B Rosenberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Peter P Zandi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

23 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

International Psychogeriatrics

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

871-889

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease

7 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Time will be of the essence in treating Alzheimer disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Neuropathologic features of amnestic mild cognitive impairment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Mediterranean diet and risk for Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Clinical aspects of inflammation in Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Global prevalence of dementia: a Delphi consensus study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Translational research on the way to effective therapy for Alzheimer disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Oxidative stress: the old enemy in Alzheimer's disease pathophysiology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

The use of biomarkers in surveillance, medical screening, and intervention

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Vitamin E and donepezil for the treatment of mild cognitive impairment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

F2-isoprostanes in Alzheimer and other neurodegenerative diseases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Mediterranean diet and cognitive decline.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

MRI and CSF studies in the early diagnosis of Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Cardiovascular risk factors and Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Alzheimer disease: mechanistic understanding predicts novel therapies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Neuroinflammatory perspectives on the two faces of Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Inflammatory processes in Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Diffusion tensor imaging in normal aging and neuropsychiatric disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Inflammation in neurodegenerative disease--a double-edged sword

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Alzheimer's disease: genes, proteins, and therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Inflammation and Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

IPF2alpha-I: an index of lipid peroxidation in humans

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Risk of Alzheimer's disease and duration of NSAID use.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Alzheimer's disease after remote head injury: an incidence study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Methods for projecting the incidence and prevalence of chronic diseases in aging populations: application to Alzheimer's disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Amyloid beta-protein and the genetics of Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Cellular and molecular biology of Alzheimer's disease and animal models

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Association of apolipoprotein E polymorphism with outcome after head injury.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

A new rating scale for Alzheimer's disease.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study.

27 June 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Relatives of the impaired elderly: correlates of feelings of burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

APOE genotype predicts when--not whether--one is predisposed to develop Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

24S-Hydroxycholesterol: a Marker of Brain Cholesterol Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Relation of education and occupation-based socioeconomic status to incident Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Functional Transitions and Active Life Expectancy Associated With Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Stroke and the risk of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

The metabolic syndrome, inflammation, and risk of cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Depression as a risk factor for Alzheimer disease: the MIRAGE Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Chronic psychological distress and risk of Alzheimer's disease in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Participation in cognitively stimulating activities and risk of incident Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Participation in novelty-seeking leisure activities and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Does participation in leisure activities lead to reduced risk of Alzheimer's disease? A prospective study of Swedish twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

In-vivo measurement of activated microglia in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Survival following a diagnosis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Clinical trial of indomethacin in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

In vivo visualization of senile-plaque-like pathology in Alzheimer's disease patients by MR microscopy on a 7T system.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Survival following dementia onset: Alzheimer's disease and vascular dementia.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Epidemiology of dementia and Alzheimer's disease.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688723

Mild cognitive impairment

3 September 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208007382

ApoE genotype and survival from intracerebral haemorrhage

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18498669

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18498669

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1017/S1041610208007382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498669%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference